SAT0711 CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH ADVANCED MALIGNANCIES AND PREEXISTING RHEUMATOLOGIC DISEASE: THE MAYO CLINIC EXPERIENCE
Background: Immune checkpoint inhibitors (specifically the anti-CTLA-4 antibody ipilimumab, and the anti-PD-1 antibodies nivolumab and pembrolizumab, have revolutionized the treatment of advanced malignancies. However, by virtue of their mechanism of action -that is, loss of T-cell inhibition and impaired self-tolerance, patients with underlying autoimmune and rheumatologic diseases were typically excluded from the clinical trials leading to the approval of these agents. Limited data, typically of single checkpoint inhibitors, exist for their safety in patients with autoimmune diseases. However, the risk for rheumatologic disease flare in patients exposed to checkpoint inhibitors is unknown. Objectives: To determine the risk of rheumatologic disease flare in patients receiving checkpoint inhibitor therapy.
Methods:
We retrospectively studied all patients who had received a checkpoint inhibitor (i.e. ipilimumab, nivolumab, pembrolizumab, or .e., waking behaviour ≤1.5 metabolic equivalents whilst sitting or lying), to be adversely linked to CVD risk in the general population. Whilst the biological processes underlying this relationship are not understood, vascular dysfunction may play a role (1, 2). However, research is yet to examine the association between sedentary behaviour and vascular function in healthy adults and/or clinical populations. Studies investigating this relationship in RA, will help to determine the extent to which sedentary behaviour may represent a modifiable risk factor for CVD in these patients. Objectives: To investigate the cross-sectional associations between sedentary behaviour and microvascular and large vessel endothelial function among patients with RA. Methods: Fifty-three patients with RA participated in the study (M age=52.9±12.8, 72% female). Laser Doppler imaging with iontophoresis was used to assess microvascular endothelium-dependent (acetylcholine, ACh) and endotheliumindependent (sodium nitroprusside, SNP) function. Large vessel endotheliumdependent and endothelium-independent functions were measured via flowmediated dilation (FMD) and glyceryl trinitrate dilation (GTN), respectively. Sedentary behaviour was self-reported via the International Physical Activity Questionnaire (hours/week sitting). Data were analysed using multiple linear regressions adjusted for traditional CVD risk factors; age, gender, total cholesterol, smoking status, family history of CVD, hypertension and body-mass-index. Results: Sitting time (hours/week, M =39.2±17.9) was significantly negatively related to % increase in perfusion in response to ACh (β=−0.30, p<0.05) and SNP (β=−0.37, p<0.01) after adjustment for traditional CVD risk factors. Sitting time accounted for 8% and 12% of the variance in microvascular endothelium-dependent function (ACh) and endothelium-independent function (SNP), respectively (traditional CVD risk factors, R 2 =0.3). No significant associations were observed between self-reported sitting time and large vessel endothelium-dependent vasodilation (FMD, β=0.16, p=0.29) or independent vasodilation (GTN, β=−0.08, p=0.55). Conclusions: Sedentary behaviour appears to adversely affect microvascular endothelial function, but not large vessel function in patients with RA. It may therefore represent a modifiable risk factor for CVD in this population. Experimental studies employing objective measures of sedentary behaviour are necessary to confirm these findings, and to determine the utility of sedentary behaviour interventions for improving vascular function and reducing CVD risk in RA. Background: From Community based COPCORD (community oriented program for control of rheumatic diseases) study in Bangladesh about a quarter of people is suffering from musculoskeletal disorders. But the study was conducted over a small number of samples and some specific localities of the country. So further study was required, covering the whole Bangladesh to justify this high prevalence. Objectives: To determine the prevalence of musculoskeletal symptoms and specific rheumatic disorders in adult population of Bangladesh. Methods: In this survey, a total of 2000 individuals aged 18 years or older were selected in twenty clusters (primary sample unit) from the seven divisions of the country. Modified COPCORD (Community Oriented Program for Control of Rheumatic Disorders) questionnaire was used to detect positive respondents. Standard criteria were used for diagnosing rheumatic disorders. Clinical judgment was used to solve diagnostic problems. Results: In total 1843 individuals were interviewed with a response rate of 92.1%. The point prevalence of musculoskeletal pain was 33.7%. It was higher in women (38.7%) than men (28.4%) and higher in rural (34.5%) than that in urban (32.4%) areas. Higher prevalence rates were observed in homemakers (16.0%), laborers
